BioSyent Announces Withdrawal of Health Canada Submissions for Cardiovascular Products
26 juin 2019 08h00 HE
|
BioSyent Inc.
TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) announces that it has informed Health Canada that it will be withdrawing its New Drug Submissions for two...
BioSyent Schedules Q4 2018 Earnings Release for March 20, 2019
15 mars 2019 12h35 HE
|
BioSyent Inc.
TORONTO, March 15, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and twelve months ended December 31, 2018...
BioSyent Schedules Q3 2018 Earnings Release for November 21, 2018
08 nov. 2018 09h22 HE
|
BioSyent Inc.
TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2018...
BioSyent Releases Q2 and H1 2018 Results
22 août 2018 08h00 HE
|
BioSyent Inc.
TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30, 2018. Key...